
|Articles|November 27, 2007
NIH to meet over use of hydroxyurea for sickle cell disease
NIH to meet over use of hydroxyurea for sickle cell disease
Advertisement
How effective is the use of hydroxyurea to treat sickle cell anemia? The National Institutes of Health will be holding a consensus conference to address this issue. Sickle cell disease is an inherited blood disorder that affects up to 75,000 people in the United States, many of whom are from sub-Saharan Africa and other areas. The
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages
2
ICER Report Finds GLP-1s Are Cost-Effective But Warns of Budget Strain
3
Vaccine Policy in Flux: Stories Pharmacists Need to Follow
4
Pharmacists Want Prescribing Authority With Proper Training, Support
5






























